Metataxonomic and Histopathological Study of Rabbit Epizootic Enteropathy in Mexico

Xiao-Haitzi Daniel Puón-Peláez1, Neil Ross McEwan2, José Guadalupe Gómez-Soto3

  • 1Doctorado en Ciencias Biológicas, Facultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Avenida de las Ciencias S/N Juriquilla, Delegación Santa Rosa Jáuregui, Santiago de Querétaro, Qro. C.P. 76230, Mexico.

Insights

Epizootic rabbit enteropathy (ERE) in young rabbits is linked to changes in gut bacteria and smaller colon crypts. This study identifies specific bacteria associated with ERE, aiding future treatment development.

Area of Science:

  • Veterinary Microbiology
  • Gastroenterology
  • Animal Pathology

Background:

  • Epizootic rabbit enteropathy (ERE) is a significant cause of enteropathy in rabbit production, particularly in Mexico.
  • The exact cause of ERE remains unclear, necessitating further investigation into its etiology.

Purpose of the Study:

  • To compare the gastrointestinal microbiota and histopathological features of healthy rabbits versus those with ERE.
  • To identify microbial and pathological differences associated with ERE.

Main Methods:

  • Metataxonomic analysis using Illumina MiSeq and the DADA2 algorithm to assess gut microbial diversity and abundance.
  • Histopathological examination of cecum, ileo-cecal valve, and colon, including crypt depth measurements.
  • Statistical analysis using PERMANOVA for microbiota and ANOVA for histopathology.

Main Results:

  • Histopathology revealed reduced colon crypt sizes in rabbits with ERE.
  • Significant differences in the diversity and abundance of gastrointestinal microbiota were observed between healthy and ERE rabbits.
  • The bacterial genera *Clostridium* and species *Cloacibacillus porcorum* and *Akkermansia muciniphila* were associated with ERE.

Conclusions:

  • The study highlights distinct microbial and histopathological profiles in rabbits affected by ERE.
  • Findings provide crucial data for understanding ERE etiology and developing targeted therapeutic strategies.